PROGRESS

Our bold achievements and ambitious future

Progress visualization

Over the past year, CAIA has taken important first steps. We secured $65 million in seed capital, partnered with major cloud providers, and began work with four leading cancer research centers.

This is the start of a $1 billion effort to expand CAIA's reach, grow its data resources, and increase its impact. The first phase focuses on proving that federated learning works in cancer research and developing a model for bringing new members on board.

Guided by experts, fueled by data

CAIA depends on both data and leadership. While the platform is fueled by patient and research data, it is guided by experts recognized across public and non-profit sectors. Traditional research funding often avoids high-risk projects, but this initiative is designed for bold ideas with high potential impact. Our leaders bring the knowledge and commitment needed to unlock AI's role in cancer research.
Expert leadership
Background pattern

Laying the groundwork

In January 2025, leaders from CAIA's founding centers and industry partners began shaping this first-of-its-kind effort.

Coordinated workstreams

Our goal is to have the first AI model ready by the end of 2025. To reach that milestone, working groups across the four centers and partner organizations are focusing on four key areas:
  • Making data accessible
  • Procuring technology
  • Developing and prioritizing use cases
  • Meeting legal and ethical requirements
  • Unified data standards

    Researchers will not see or handle data from other centers directly. Instead, AI models will train across distributed datasets. For this to work, the data must be consistent across institutions. CAIA is standardizing data formats and storage methods so every participating center can contribute in the same way.

    Roadmap

    CAIA has ambitious goals and a clear plan for achieving them.

    PHASE 1 - 2025

    Build and validate

    Form the alliance

    Develop a scalable AI model

    Test and validate across founding cancer centers

    PHASE 2 - 2026 and beyond

    Expand and grow

    Open CAIA models to the wider biomedical community

    Add more data, partners, and research use cases

    Drive innovation and sustain long-term growth